ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

Committee Drafts QRA Definition

November 19, 1982

Scientist’s Interpretation Of Meta-Analysis On ESAs Turns 180 Degrees Over 72 Hours.

June 8, 2007

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

CIIT’s Swenberg Denies He Is NTP “Industry Representative”

December 12, 1980

Study Finds Physician Referral By Centers Fraught With Problems, Potential Dangers

July 23, 1976